What Systemic Hormone Therapy Black Box Removal Means for Breast Cancer SurvivorsWhat Systemic Hormone Therapy Black Box Removal Means for Breast Cancer Survivors
This Viewpoint discusses the benefits and risks of systemic hormone therapy in breast cancer survivors following the US Food and Drug Administration’s removal of black box warnings from menopausal hormone therapy.
Quarter of healthy years lost to breast cancer are due to lifestyle factors, research findsQuarter of healthy years lost to breast cancer are due to lifestyle factors, research finds
Largest study of its kind suggests high red meat consumption has biggest impact, followed by smokingMore than a quarter of healthy years lost to breast cancer are due to lifestyle factors such as red meat intake and smoking, according to the largest study of its kind.The study, published in the Lancet Oncology, used data from population-based cancer registries to produce a comprehensive analysis of breast cancer and its risk factors. Continue reading…
Breast cancer still most common cancer among women worldwide, with annual cases expected to exceed 3.5 million by 2050Breast cancer still most common cancer among women worldwide, with annual cases expected to exceed 3.5 million by 2050
Despite recent advancements in breast cancer treatments, new breast cancer cases in women are predicted to rise by a third globally from 2.3 million in 2023 to more than 3.5 million in 2050. Similarly, yearly deaths from the disease are projected to surge 44%, from around 764,000 to 1.4 million, with disproportionate impact in countries with limited resources, according to a major new analysis from the Global Burden of Disease Study Breast Cancer Collaborators, published in The Lancet Oncology.
Breast cancer screening with MRI provides modest benefit for high-risk womenBreast cancer screening with MRI provides modest benefit for high-risk women
1. For women at higher-than-average risk, adding supplemental MRI to DBT provided only modest additional benefit, resulting in a similar harm-benefit balance compared with DBT alone. 2. Across all risk levels, biennial DBT starting at age 50 was the most cost-effective strategy. Evidence Rating Level: 2 (Good) Study Rundown: A substantial proportion of women undergoing
The post Breast cancer screening with MRI provides modest benefit for high-risk women first appeared on 2 Minute Medicine. Source: 2 Minute Medicine
GLP-1 Drugs May Work Differently in WomenGLP-1 Drugs May Work Differently in Women
(MedPage Today) — Women lost more weight than men while using GLP-1 receptor agonists, a systematic review and meta-analysis of randomized clinical trials showed. Among six trials that analyzed outcomes for nearly 20,000 participants by sex… (MedPage Today) — Women lost more weight than men while using GLP-1 receptor agonists, a systematic review and Read More
GLP-1 drugs associated with reduced need for emergency care for migraineGLP-1 drugs associated with reduced need for emergency care for migraine
For people with chronic migraine, taking glucagon-like peptide-1 receptor agonists, or GLP-1 drugs, for other conditions such as diabetes and weight loss, was associated with fewer emergency department visits and hospitalizations overall, and with less need for medications used to stop and prevent migraine attacks, according to a preliminary study being presented at the American Read More
GLP-1s may increase risk of osteoporosis and gout, new research findsGLP-1s may increase risk of osteoporosis and gout, new research finds
GLP-1 drugs — including Ozempic and Wegovy — may be tied to a slightly higher risk of osteoporosis and gout, according to research presented Monday at the American Academy of Orthopaedic Surgeons’ annual meeting.Dr. GLP-1 drugs — including Ozempic and Wegovy — may be tied to a slightly higher risk of osteoporosis and gout, according Read More
Use of Complementary and Alternative Medicine in the Management of Breast CancerUse of Complementary and Alternative Medicine in the Management of Breast Cancer
This cohort study assesses the association of complementary and alternative medicine plus traditional therapies, including surgery, chemotherapy, radiation, endocrine therapy, and immunotherapy, with survival in female patients with breast cancer.
GLP-1 Drugs Tied to Unexpected Migraine BenefitsGLP-1 Drugs Tied to Unexpected Migraine Benefits
(MedPage Today) — Chronic migraine patients who used GLP-1 receptor agonists to treat conditions like obesity or diabetes had fewer emergency department (ED) visits than those on topiramate (Topamax), a real-world data analysis showed. Compared… (MedPage Today) — Chronic migraine patients who used GLP-1 receptor agonists to treat conditions like obesity or diabetes had Read More
Hidden ingredient in Ozempic and Wegovy tablets raises new gut health questionsHidden ingredient in Ozempic and Wegovy tablets raises new gut health questions
Scientists are taking a closer look at the pill forms of Wegovy and Ozempic. In an animal study, the ingredient SNAC, which helps semaglutide survive the stomach and enter the bloodstream, was associated with changes in gut bacteria, inflammation markers, and a brain linked protein. The research does not show harm in people, but it Read More